iDose in Beverly Hills
Advanced Glaucoma Care with iDose
A breakthrough in long-term glaucoma management, iDose delivers continuous medication with a single, simple procedure.
A New Era in Glaucoma Care
Glaucoma treatment no longer has to mean daily drops and constant reminders. At Beverly Hills Institute of Ophthalmology, we offer iDose—a sustained-release implant that provides long-term intraocular pressure (IOP) control that comes with fewer burdens and more consistency.
What Is iDose?
iDose is a tiny, FDA-approved implant that delivers continuous medication directly inside the eye to help manage open-angle glaucoma or ocular hypertension. iDose slowly releases a trusted IOP-lowering medication (Travoprost) over time, which helps reduce or end the need for daily eye drops. iDose involves insertion with a minimally invasive procedure.
Roughly the size of a grain of rice, the iDose implant is placed inside the trabecular meshwork of the eye, where it begins delivering medication immediately and continuously.
Why Choose Beverly Hills Institute of Ophthalmology?
- Expert glaucoma specialists – Our team includes experienced ophthalmologists with advanced training in medical and surgical glaucoma care.
- Cutting-edge technology – We proudly offer next-generation treatment options like iDose to patients seeking long-term control without the hassle of daily drops.
- Precision and safety – Our focus on minimally invasive techniques and evidence-based care ensures safety, comfort, and optimal results.
- Personalized treatment plans – We believe in creating tailored solutions for each patient’s unique lifestyle, diagnosis, and treatment goals.
What Are the Benefits?
- Long-term IOP control with a single implant
- Reduced or no more need for daily glaucoma drops
- Improved medication adherence and peace of mind
- Minimally invasive outpatient procedure
- Low risk of systemic side effects or medication error
Who Is a Candidate?
- iDose may be appropriate for patients with:
- Primary open-angle glaucoma or ocular hypertension
- A history of poor compliance with eye drops
- Sensitivities or side effects related to topical medications
- Desire for a drop-free, low-maintenance option
- A thorough exam at Beverly Hills Institute of Ophthalmology will determine your candidacy and guide the best treatment approach.
The Procedure: What to Expect?
Before the Procedure
You’ll undergo a full glaucoma evaluation to confirm that iDose is the right option for your condition. Preoperative instructions will be provided to ensure comfort and safety.
During the Procedure
iDose is implanted during a quick, in-office or outpatient surgical procedure—often performed at the same time as cataract surgery. Local anesthesia is used, and the entire process typically takes less than 15 minutes.
After the Procedure
Most patients experience minimal discomfort and return to normal activities within a day or two. Follow-up visits will be scheduled to monitor IOP and healing progress.
Eye Recovery After iDose
- Mild irritation or blurred vision may occur for 24–48 hours
- Avoid strenuous activities for the first few days
- Continue prescribed anti-inflammatory drops as directed
- Attend follow-up appointments to assess eye pressure and implant function
What Are the Long-Term Results?
The iDose implant is designed to provide sustained IOP control for months to years. Clinical trials have shown significant pressure reduction and reduced reliance on additional medications for many patients. Future implants can be placed if additional treatment is needed, offering ongoing management with minimal disruption.
FAQ: iDose for Glaucoma
How long does iDose last?
Studies show that iDose can reduce eye pressure for up to a year or more, though individual results may vary.
Is the implant visible or uncomfortable?
No. The implant is microscopic and cannot be seen or felt once placed.
Can I still use eye drops if I have iDose?
Yes, if needed. While many patients reduce or stop their drops after iDose, additional medications can be added later if required.
Is iDose safe?
Yes. iDose has undergone rigorous clinical trials and is FDA-approved as a safe and effective option for glaucoma management.
Can iDose be done with cataract surgery?
Absolutely. iDose is often placed during cataract surgery to address both vision and eye pressure in a single procedure.
Schedule Your Consultation
If you’re ready for a simpler, more consistent approach to glaucoma treatment, iDose may be the solution. Contact Beverly Hills Institute of Ophthalmology to schedule your personalized evaluation today.